Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
VTYX

VTYX - Ventyx Biosciences, Inc. Stock Price, Fair Value and News

$13.96-0.03 (-0.21%)
Market Closed

Price Targets

VTYX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

VTYX Price Action

Last 7 days

0.7%

Last 30 days

53.7%

Last 90 days

65.8%

Trailing 12 Months

591.1%

VTYX RSI Chart

VTYX Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

VTYX Valuation

Market Cap

996.2M

Price/Earnings (Trailing)

-9.34

Price/Free Cashflow

-11.34

VTYX Price/Earnings (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

VTYX Fundamentals

VTYX Earnings

Earnings (TTM)

-106.6M

Earnings Growth (Yr)

35.24%

Earnings Growth (Qtr)

15.41%

VTYX Profitability

Return on Equity

-55.71%

Return on Assets

-50.41%

Free Cashflow Yield

-8.82%

VTYX Investor Care

Shares Dilution (1Y)

0.92%

Diluted EPS (TTM)

-1.47

About Ventyx Biosciences, Inc.

VTYX
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates to address a range of inflammatory diseases. Its lead clinical product candidate is VTX958, a selective allosteric tyrosine kinase type 2 inhibitor for psoriasis, psoriatic arthritis, and Crohn's disease. It is also developing VTX002, a sphingosine 1 phosphate receptor modulator that is in Phase II clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral-targeted NOD-like receptor protein 3 inflammasome inhibitor to treat patients with cryopyrin-associated periodic syndrome. In addition, the company develops VTX3232, a CNS-penetrant NLRP3 inhibitor. Ventyx Biosciences, Inc. was incorporated in 2018 and is based in Encinitas, California.
 CEO
 WEBSITEhttps://ventyxbio.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES91

Ventyx Biosciences, Inc. Frequently Asked Questions

VTYX is the stock ticker symbol of Ventyx Biosciences, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Ventyx Biosciences, Inc. is 996.17 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check VTYX's fair value in chart for subscribers.

The fair value guage provides a quick view whether VTYX is over valued or under valued. Whether Ventyx Biosciences, Inc. is cheap or expensive depends on the assumptions which impact Ventyx Biosciences, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for VTYX.